Utilizing the Space‐Charge Region of the FeNi‐LDH/CoP p‐n Junction to Promote Performance in Oxygen Evolution Electrocatalysis

The modulation of electron density is an effective option for efficient alternative electrocatalysts. Here, p‐n junctions are constructed in 3D free‐standing FeNi‐LDH/CoP/carbon cloth (CC) electrode (LDH=layered double hydroxide). The positively charged FeNi‐LDH in the space‐charge region can significantly boost oxygen evolution reaction. Therefore, the j at 1.485 V (vs. RHE) of FeNi‐LDH/CoP/CC achieves ca. 10‐fold and ca. 100‐fold increases compared to those of FeNi‐LDH/CC and CoP/CC, respectively. Density functional theory calculation reveals OH^? has a stronger trend to adsorb on the surface of FeNi‐LDH side in the p‐n junction compared to individual FeNi‐LDH further verifying the synergistic effect in the p‐n junction. Additionally, it represents excellent activity toward water splitting. The utilization of heterojunctions would open up an entirely new possibility to purposefully regulate the electronic structure of active sites and promote their catalytic activities.     

开设实验选修课培养学生创新能力

介绍了复旦大学物理教学实验中心为培养学生创新能力开设的4门实验选修课的特点、要求以及在培养学生创新能力方面取得的成效。     

中药川白芷化学成分的研究

中药川白芷为伞形科当归属杭白芷 (Ａｎｇｅｌｉｃａｄａｈｕｒｉｃａ (Ｆｉｓｃｈ .ｅｘＨｏｆｆｍ .)Ｂｅｎｔｈ .ｅｔＨｏｏｋ .ｃｖｈａｎｇ ｂａｉｚｈｉＨｏｒｔ)的干燥根。川白芷为我国传统中药 ,主治头疼、鼻炎、癣症等疾病。现代药理实验表明白芷中所含的呋南香豆素具有平喘、降压、抗菌、解痉、光敏、活化交感系激素等多种药理作用[1] 。已有文献对白芷的化学成分进行了研究 ,发现白芷中主要含香豆素成分[2～ 4] 。四川遂宁产川白芷为道地白芷 ,其药性好 ,为进一步研究其活性成分 ,本文对遂宁产川白芷进行化学成分研究。共分离、…     

合成2—芳氧基—5—氟—3H—4—嘧啶酮的新方法

由２－氰－５－氟－３Ｈ－４－嘧啶酮和取代苯酚钠在常压下反应，合成了７个未见文献报道的２－芳氧基－５－氟－３Ｈ－４－嘧啶酮化合物，产率７０￣８７％，结构经ＩＲ、＾１Ｈ ＮＭＲ和ＭＳ证实。     

嘧啶基苯硫甲基磺酰脲化合物的合成及除草活性

４，６－二氯－２－嘧啶基苯硫甲基磺酰脲与甲醇钠反应，合成了１５个 见文献报道的标题化合物。它们的结构经ＩＲ，＾１ＨＮＭＲ，ＭＳ，元素分析证实。其中一类化合物具有较强除草活性。     

无外加催化剂条件下芳香醛与活性亚甲基化合物的缩合反应和迈克尔加成反应

在DMF溶剂中,不外加催化剂使芳香醛(1)与2,2-二甲基-1,3-二氧六环-4,6-二酮(2)发生缩合反应生成2,2-二甲基-5-芳亚甲基-1,3-二氧六环-4,6-二酮(3a～f)。在同样条件下,芳香醛与5,5-二甲基-1,3-环己二酮(4)则发生缩合和迈克尔加成反应生成2,2’-芳亚甲基双(3-羟基-5,5-二甲基-2-环己烯-1-酮)(5a～h)。用单晶X-射线分析法确定了产物5b的晶体结构。     

N—乙基—N—苄基苯胺合成方法的改进

以苯胺和乙醇为原料，采用ＲａｎｅｙＮｉ为催化剂，合成了Ｎ－乙基苯胺，再在相转移催化剂作用下，经苄基化反应得到标题化合物，第一步合成方法的收率比通常方法的收率提高约３０％。     

含参广义集值强向量平衡问题的稳定性

本文借助集合极限的性质和弱f-性假设证明了含参广义集值强向量平衡问题解集映射的下半连续性,其方法不同于最近文献(Zhao,2016和Meng,2018).此外,建立了含参广义集值强向量平衡问题解集连通性的充分条件,并举例验证了所得结果的正确性.本文得结果推广和改进了已有文献(Gong,2008,Xu,2009,Chen,2010,Xu,2013和Zhao,2013)中相应结果.     

Cube‐in‐Cube Hollow Cu9S5 Nanostructures with Enhanced Photocatalytic Activities in Solar H2 Evolution

Hydrogen produced from water under solar energy is an ideal clean energy source, and the efficiency of hydrogen production usually depends on the catalytic systems based on new compounds and/or a unique nanostructure. Herein, well‐defined cube‐in‐cube hollow Cu₉S₅ nanostructures have been successfully prepared with Cu₂O nanocubes and CS₂ as precursors, and single‐shell hollow Cu₉S₅ nanocubes could be obtained by replacing CS₂ with Na₂S. The formation mechanism of cube‐in‐cube hollow nanostructures has been proposed based on the Kirkendell effect and an outward self‐assembly process. Further studies revealed that the cube‐in‐cube hollow Cu₉S₅ nanostructures exhibited better photocatalytic activity toward solar H₂ evolution and would be a promising photocatalyst in the solar hydrogen industry.     

Ribbon of DNA Lattice on Gold Nanoparticles for Selective Drug Delivery to Cancer Cells

Herein, we report on the design of a programmable DNA ribbon using long‐chain DNA molecules with a user‐defined repetitive padlock sequence. The DNA ribbon can be further combined with gold nanoparticles (AuNPs) to create a composite nanomaterial that contains an AuNP core and a high‐density DNA crown carrying a cancer‐cell‐targeting DNA aptamer, a fluorescent tag for location tracking, and a cell‐killing drug. This composite material can be efficiently internalized by cancer cells and its cellular location can be tracked by fluorescence imaging. The system offers several attractive characteristics, including simple design, tunable DNA crown, high drug‐loading capacity, selective cell targeting, and pH‐sensitive drug release. These features make such a material a promising therapeutic agent.